Anbio Biotechnology banner
A

Anbio Biotechnology
NASDAQ:NNNN

Watchlist Manager
Anbio Biotechnology
NASDAQ:NNNN
Watchlist
Price: 27.15 USD -2.34% Market Closed
Market Cap: $3.9B

Anbio Biotechnology
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Anbio Biotechnology
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
A
Anbio Biotechnology
NASDAQ:NNNN
Other Items
-4.2m
CAGR 3-Years
-40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Other Items
-€1.7B
CAGR 3-Years
N/A
CAGR 5-Years
-96%
CAGR 10-Years
N/A
CureVac NV
NASDAQ:CVAC
Other Items
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Other Items
€211.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Other Items
-€16.9m
CAGR 3-Years
14%
CAGR 5-Years
-50%
CAGR 10-Years
19%
Formycon AG
XETRA:FYB
Other Items
€28.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
228%
No Stocks Found

Anbio Biotechnology
Glance View

Market Cap
3.9B USD
Industry
Biotechnology

Anbio Biotechnology is a DE-based company operating in Biotechnology industry. The company is headquartered in Frankfurt, Hessen. The company went IPO on 2025-02-19. Anbio Biotechnology is a Germany-based company. The firm is primarily engaged in the manufacturing of In Vitro Diagnostic Substance.

NNNN Intrinsic Value
Not Available
A

See Also

What is Anbio Biotechnology's Other Items?
Other Items
-4.2m

Based on the financial report for Dec 31, 2025, Anbio Biotechnology's Other Items amounts to -4.2m .

What is Anbio Biotechnology's Other Items growth rate?
Other Items CAGR 3Y
-40%

The average annual Other Items growth rates for Anbio Biotechnology have been -40% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett